Drug intelligence / Profile preview

RD01

Development stage
Preclinical
Lead developer
Lineage Cell Therapeutics
Modality
iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
Administration
Subcutaneous, Intravenous
01

Overview

RD01 is an induced pluripotent stem cell (iPSC)-derived cell therapy program being developed by Lineage Cell Therapeutics in collaboration with Factor Bioscience. The program utilizes Factor Bioscience's proprietary mRNA-based cell-reprogramming and gene-editing technologies to generate specialized cell types intended for the treatment of various neurological disorders. Currently in the discovery to preclinical stage, the specific neural cell lineage and exact mechanism of action have not been publicly disclosed. The therapy aims to leverage the regenerative potential of iPSC-derived cells to address unmet medical needs in neurology, potentially through the replacement or repair of damaged neural tissues.

Other names
RD01-LINEAGE-iPSC-derived cells-Neurological disordersRD-01-LINEAGE-iPSC-derived cells-Neurological disordersRD 01-LINEAGE-iPSC-derived cells-Neurological disorders

Beyond the preview

Go deeper on RD01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RD01.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call